Liber Pharmaceuticals

Setting the standard for Inhaled Nicotine Replacement Therapies

Liber aims to prove the safety and efficacy of inhalation-based therapies as methods of administering medicines.

Through its suite of inhaled Nicotine Replacement Therapy (iNRT) products, Liber is focused on vaporiser technology as an intervention for smoking cessation.

Nicovape Q

The
Liber
difference

01

Locally supplied and insured

Liber is the only Nicotine Vaping Product (NVP) manufacturer who has acquired Australian-issued product liability insurance.

02

Characterised and assessed liquids

Characterisation of all flavour compounds, subjected to comprehensive toxicological risk and hazard assessments for inhalation.

03

Domestic pharmacy distribution

Nicovape® Q is the only NVP supplied by pharmaceutical wholesalers (Symbion and API) to over 5,500 community pharmacies nationwide.

Nicotine Vaping Pharmacies

Find us in your local pharmacy

Over 2,000 community pharmacies nationwide currently hold stock of the Nicovape® Q range in-store.

Interested in stocking Nicovape® Q?
Speak with your national wholesaler SAS representative

vaping mistakes
International news & media

Postcard from America – vaping mistakes

How one of vaping’s biggest success stories became a reputational nightmare, and how not to repeat the same mistakes in Australia.

Nicotine Vaping Pharmacies

Find us in your local pharmacy

Over 2,000 community pharmacies nationwide currently hold stock of the Nicovape® Q range in-store.

Interested in stocking Nicovape® Q?

Speak with your national wholesaler SAS rep

Liber News
vaping mistakes
International news & media

Postcard from America – vaping mistakes

How one of vaping’s biggest success stories became a reputational nightmare, and how not to repeat the same mistakes in Australia.

Prescribing doctors

Register now as an Authorised Prescriber

Healthcare professionals

Visit the iNRT healthcare education portal

Consumers

Speak with a GP about quitting smoking